<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10</volume><submitter>Aris M</submitter><funding>Instituto Nacional del Cáncer</funding><pubmed_abstract>The CSF-470 cellular vaccine plus BCG and rhGM-CSF increased distant metastases-free survival in cutaneous melanoma patients stages IIB-IIC-III relative to medium dose IFN-α2b (CASVAC-0401 study). Patient-045 developed a mature vaccination site (VAC-SITE) and a regional cutaneous metastasis (C-MTS), which were excised during the protocol, remaining disease-free 36 months from vaccination start. CDR3-TCRβ repertoire sequencing in PBMC and tissue samples, along with skin-DTH score and IFN-γ ELISPOT assay, were performed to analyze the T-cell immune response dynamics throughout the immunization protocol. Histopathological analysis of the VAC-SITE revealed a highly-inflamed granulomatous structure encircled by CD11c+ nested-clusters, brisk CD8+ and scarce FOXP3+, lymphocytes with numerous Lang</pubmed_abstract><journal>Frontiers in immunology</journal><pagination>2213</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6759869</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood.</pubmed_title><pmcid>PMC6759869</pmcid><pubmed_authors>Bravo AI</pubmed_authors><pubmed_authors>Blanco PA</pubmed_authors><pubmed_authors>Bentivegna S</pubmed_authors><pubmed_authors>Carri I</pubmed_authors><pubmed_authors>Aris M</pubmed_authors><pubmed_authors>Garcia Alvarez HM</pubmed_authors><pubmed_authors>Barrio MM</pubmed_authors><pubmed_authors>Mordoh J</pubmed_authors><pubmed_authors>Nielsen M</pubmed_authors><pubmed_authors>Podaza E</pubmed_authors><pubmed_authors>Rotondaro C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood.</name><description>The CSF-470 cellular vaccine plus BCG and rhGM-CSF increased distant metastases-free survival in cutaneous melanoma patients stages IIB-IIC-III relative to medium dose IFN-α2b (CASVAC-0401 study). Patient-045 developed a mature vaccination site (VAC-SITE) and a regional cutaneous metastasis (C-MTS), which were excised during the protocol, remaining disease-free 36 months from vaccination start. CDR3-TCRβ repertoire sequencing in PBMC and tissue samples, along with skin-DTH score and IFN-γ ELISPOT assay, were performed to analyze the T-cell immune response dynamics throughout the immunization protocol. Histopathological analysis of the VAC-SITE revealed a highly-inflamed granulomatous structure encircled by CD11c+ nested-clusters, brisk CD8+ and scarce FOXP3+, lymphocytes with numerous Lang</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2025-04-04T07:52:17.063Z</modification><creation>2019-10-30T08:17:30Z</creation></dates><accession>S-EPMC6759869</accession><cross_references><pubmed>31620131</pubmed><doi>10.3389/fimmu.2019.02213</doi></cross_references></HashMap>